AAAAAA

   
Results: 1-21 |
Results: 21
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions
Authors: Laczika, K Mitterbauer, G Mitterbauer, M Knobl, P Schwarzinger, I Greinix, HT Rabitsch, W Fonatsch, C Mannhalter, C Lechner, K Jaeger, U
Citation: K. Laczika et al., Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions, LEUK LYMPH, 42(5), 2001, pp. 923-931
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants
Authors: Keil, F Prinz, F Kalhs, P Lechner, K Moser, K Schwarzinger, I Jager, U Fonatsch, C Worel, N Mannhalter, C Rabitsch, W Loidolt, H Schulenburg, A Mitterbauer, M Hocker, P Greinix, HT
Citation: F. Keil et al., Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants, LEUKEMIA, 15(3), 2001, pp. 355-361
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR
Authors: Schulenburg, A Watkins-Riedel, T Greinix, HT Rabitsch, W Loidolt, H Keil, F Mitterbauer, M Kalhs, P
Citation: A. Schulenburg et al., CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR, BONE MAR TR, 28(8), 2001, pp. 765-768
Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation
Authors: Rabitsch, W Deviatko, E Keil, F Herold, C Dekan, G Greinix, HT Lechner, K Klepetko, W Kalhs, P
Citation: W. Rabitsch et al., Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation, TRANSPLANT, 71(9), 2001, pp. 1341-1343
Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease
Authors: Zauner, C Rabitsch, W Schneeweiss, B Schiefermeier, M Greinix, HT Keil, F Ratheiser, K Kalhs, P
Citation: C. Zauner et al., Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease, TRANSPLANT, 71(4), 2001, pp. 524-528
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR
Authors: Keil, F Mitterbauer, G Chen, X Haas, OA Kalhs, P Lechner, K Mannhalter, C Moser, K Worel, N Pirc-Danoewinata, H Louda, N Loidolt, H Rabitsch, W Greinix, HT
Citation: F. Keil et al., PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR, TRANSFUSION, 41(1), 2001, pp. 111-116
Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: Successful second transplantation with allogeneic peripheral blood progenitor cells
Authors: Reiter, E Rabitsch, W Greinix, HT Keil, F Mitterbauer, G Hinterberger, W Haas, OA Lechner, K Kalhs, P
Citation: E. Reiter et al., Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: Successful second transplantation with allogeneic peripheral blood progenitor cells, LEUK LYMPH, 40(1-2), 2000, pp. 215-218
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26)
Authors: Reiter, E Greinix, H Rabitsch, W Keil, F Schwarzinger, I Jaeger, U Lechner, K Worel, N Streubel, B Fonatsch, C Mitterbauer, G Kalhs, P
Citation: E. Reiter et al., Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversion inv (3)(q-21q26) or homologous translocation t(3;3) (q21;q26), ANN HEMATOL, 79(7), 2000, pp. 374-377
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia
Authors: Greinix, HT Loidolt, H Rabitsch, W Schulenburg, A Keil, F Mitterbauer, M Laczika, K Lechner, K Dieckmann, K Fischer, G Jager, U Rosenmayr, A Knobl, P Schwarzinger, I Hocker, P Mannhalter, C Hinterberger, W Haas, OA Fonatsch, C Kalhs, P
Citation: Ht. Greinix et al., Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia, ANN HEMATOL, 79(4), 2000, pp. 206-213
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients
Authors: Greinix, HT Linkesch, W Seifert, M Kubista, E Czerwenka, K Elahi, F Zielinski, C Hoecker, P Steger, G Schulenburg, A Neumeister, G Rabitsch, W Jakesz, R Kalhs, P
Citation: Ht. Greinix et al., Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients, ACTA ONCOL, 39(1), 2000, pp. 47-52
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems
Authors: Worel, N Greinix, HT Schneider, B Kurz, M Rabitsch, W Knobl, P Reiter, E Derfler, K Fischer, G Hinterberger, W Hocker, P Kalhs, P
Citation: N. Worel et al., Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems, TRANSFUSION, 40(5), 2000, pp. 543-550
Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route
Authors: Laczika, K Thalhammer, F Locker, G Apsner, R Losert, H Kofler, J Rabitsch, W Mares, P Frass, M Sunder-Plassmann, G Muhm, M
Citation: K. Laczika et al., Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route, ANESTH ANAL, 90(4), 2000, pp. 784-789
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation
Authors: Keil, F Kalhs, P Chen, X Haas, OA Fritsch, G Chott, A Lechner, K Moser, K Ackermann, J Rabitsch, W Worel, N Mannhalter, C Greinix, HT
Citation: F. Keil et al., Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation, ANN HEMATOL, 78(8), 1999, pp. 376-379
Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature
Authors: Reiter, E Kalhs, P Keil, F Rabitsch, W Gisslinger, H Mayer, G Worel, N Lechner, K Greinix, HT
Citation: E. Reiter et al., Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature, ANN HEMATOL, 78(4), 1999, pp. 189-191
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia
Authors: Reiter, E Greinix, HT Keil, F Brugger, S Rabitsch, W Schulenburg, A Mannhalter, C Schwarzinger, I Worel, N Volc-Platzer, B Fischer, G Dieckmann, K Hinterberger, W Schneider, B Haas, OA Geissler, K Kalhs, P
Citation: E. Reiter et al., Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia, ANN HEMATOL, 78(11), 1999, pp. 507-513
Central venous catheters inserted percutaneously via the femoral vein can be used long-term in recipients of allogeneic peripheral blood stem cell transplants
Authors: Rabitsch, W Kalhs, P Herold, C Jaeger, U Greinix, HT
Citation: W. Rabitsch et al., Central venous catheters inserted percutaneously via the femoral vein can be used long-term in recipients of allogeneic peripheral blood stem cell transplants, BONE MAR TR, 24(1), 1999, pp. 115-116
Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia
Authors: Kalhs, P Brugger, S Reiter, E Keil, F Fischer, G Schulenburg, A Rabitsch, W Rosenmayr, A Dieckmann, K Kurz, M Schwarzinger, I Volc-Platzer, B Mannhalter, C Lechner, K Greinix, HT
Citation: P. Kalhs et al., Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia, BONE MAR TR, 23(8), 1999, pp. 753-758
Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD)
Authors: Gmeinhart, B Hinterberger, W Greinix, HT Rabitsch, W Kirnbauer, R Reiter, E Volc-Platzer, B
Citation: B. Gmeinhart et al., Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD), BONE MAR TR, 23(11), 1999, pp. 1197-1199
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia
Authors: Reiter, E Greinix, HT Mitterbauer, G Fischer, G Keil, F Mannhalter, C Rabitsch, W Schwarzinger, I Worel, N Lechner, K Kalhs, P
Citation: E. Reiter et al., Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia, ANN HEMATOL, 77(6), 1998, pp. 283-286
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies
Authors: Rabitsch, W Reiter, E Keil, F Malzer, R Leitner, G Fischer, G Dieckman, K Kalhs, P Lechner, K Greinix, HT
Citation: W. Rabitsch et al., Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies, BONE MAR TR, 22, 1998, pp. S49-S52
Long term follow up after allogeneic stem cell transplantation for chronicmyelogenous leukemia
Authors: Reiter, E Greinix, HT Brugger, S Keil, F Rabitsch, W Mannhalter, C Schwarzinger, I Hocker, P Fischer, G Dieckmann, M Hinterberger, W Linkesch, W Schneider, B Lechner, K Kalhs, P
Citation: E. Reiter et al., Long term follow up after allogeneic stem cell transplantation for chronicmyelogenous leukemia, BONE MAR TR, 22, 1998, pp. S86-S88
Risultati: 1-21 |